Literature DB >> 34775552

The central executive network and executive function in healthy and persons with schizophrenia groups: a meta-analysis of structural and functional MRI.

Malvina O Pietrzykowski1, Katrina M Daigle2, Abigail B Waters2, Lance P Swenson2, David A Gansler2.   

Abstract

This meta-analysis evaluated the extent to which executive function can be understood with structural and functional magnetic resonance imaging. Studies included structural in schizophrenia (k = 8; n = 241) and healthy controls (k = 12; n = 1660), and functional in schizophrenia (k = 4; n = 104) and healthy controls (k = 12; n = 712). Results revealed a positive association in the brain behavior relationship when pooled across schizophrenia and control samples for structural (pr = 0.27) and functional (pr = 0.29) modalities. Subgroup analyses revealed no significant difference for functional neuroimaging (pr = .43, 95%CI = -.08-.77, p = .088) but with structural neuroimaging (pr = .37, 95%CI = -.08-.69, p = .015) the association to executive functions is lower in the control group. Subgroup analyses also revealed no significant differences in the strength of the brain-behavior relationship in the schizophrenia group (pr = .59, 95%CI = .58-.61, p = .881) or the control group (pr = 0.19, 95%CI = 0.18-0.19, p = 0.920), suggesting concordance.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Central executive network; Executive function; MRI; Meta-analysis; Schizophrenia

Mesh:

Year:  2021        PMID: 34775552     DOI: 10.1007/s11682-021-00589-3

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  51 in total

1.  A simple objective technique for measuring flexibility in thinking.

Authors:  E A BERG
Journal:  J Gen Psychol       Date:  1948-07

2.  Interactions of the Salience Network and Its Subsystems with the Default-Mode and the Central-Executive Networks in Normal Aging and Mild Cognitive Impairment.

Authors:  Ganesh B Chand; Junjie Wu; Ihab Hajjar; Deqiang Qiu
Journal:  Brain Connect       Date:  2017-08-10

Review 3.  Executive functions.

Authors:  Adele Diamond
Journal:  Annu Rev Psychol       Date:  2012-09-27       Impact factor: 24.137

Review 4.  Fifty Years of Prefrontal Cortex Research: Impact on Assessment.

Authors:  Paul W Burgess; Donald T Stuss
Journal:  J Int Neuropsychol Soc       Date:  2017-10       Impact factor: 2.892

5.  Specific measures of executive function predict cognitive decline in older adults.

Authors:  Lindsay R Clark; Dawn M Schiehser; Gali H Weissberger; David P Salmon; Dean C Delis; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

6.  Network localization of heterogeneous neuroimaging findings.

Authors:  R Ryan Darby; Juho Joutsa; Michael D Fox
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

7.  Substance use in youth at risk for psychosis.

Authors:  R Carney; A R Yung; G P Amminger; T Bradshaw; N Glozier; D F Hermens; I B Hickie; E Killackey; P McGorry; C Pantelis; S J Wood; R Purcell
Journal:  Schizophr Res       Date:  2016-08-31       Impact factor: 4.939

8.  Regional differences in brain volume predict the acquisition of skill in a complex real-time strategy videogame.

Authors:  Chandramallika Basak; Michelle W Voss; Kirk I Erickson; Walter R Boot; Arthur F Kramer
Journal:  Brain Cogn       Date:  2011-05-04       Impact factor: 2.310

9.  Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder.

Authors:  James M Bjork; Steven J Grant; Daniel W Hommer
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

10.  Altered resting-state functional organization within the central executive network in obsessive-compulsive disorder.

Authors:  Yunhui Chen; Xin Meng; Qiang Hu; Hongsheng Cui; Yongzhuo Ding; Lu Kang; Michal Juhás; Andrew J Greenshaw; Ameng Zhao; Yuhua Wang; Guangcheng Cui; Ping Li
Journal:  Psychiatry Clin Neurosci       Date:  2016-08-28       Impact factor: 5.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.